VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Centering Pregnancy Care + Yoga for Diverse Pregnant Women

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Behavioral: Centering Pregnancy Care plus Yoga (CPC+Y)

First Posted Date: 2016-08-19

Last Posted Date: 2018-06-06

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 40

Registration Number: NCT02873481

Locations: 🇺🇸
Virginia Commonwealth University School of Nursing, Richmond, Virginia, United States

Addressing Modifiable Breast Cancer Risk Factors With Project CONECT

Not Applicable

Completed

Conditions: Weight Loss
Breast Cancer Risk Factors

Interventions: Behavioral: CONECT

First Posted Date: 2016-08-18

Last Posted Date: 2019-07-09

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 14

Registration Number: NCT02871388

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

SGLT2 Inhibition in Diabetes and Heart Failure

Completed

Conditions: Heart Failure, Systolic
Diabetes Mellitus, Type 2

First Posted Date: 2016-08-10

Last Posted Date: 2018-07-16

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 18

Registration Number: NCT02862067

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease

Phase 1

Completed

Conditions: Constipation
Gastroparesis
Parkinson's Disease

Interventions: Drug: Placebo
Drug: RQ-00000010

First Posted Date: 2016-07-20

Last Posted Date: 2019-10-09

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 51

Registration Number: NCT02838797

Locations: 🇺🇸
VCU NOW Center, Henrico, Virginia, United States

TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome

Phase 1

Completed

Conditions: Mycosis Fungoides
Sézary Syndrome

Interventions: Radiation: TSEB Therapy
Drug: Brentuximab vedotin

First Posted Date: 2016-07-04

Last Posted Date: 2019-08-30

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 5

Registration Number: NCT02822586

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer

Phase 1

Terminated

Conditions: Renal Cell Carcinoma
Metastatic Disease
Soft Tissue Sarcoma

Interventions: Drug: AR-42
Drug: Pazopanib

First Posted Date: 2016-06-10

Last Posted Date: 2019-10-24

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 6

Registration Number: NCT02795819

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System

Phase 1

Terminated

Conditions: Obstetric Anesthesia
Cesarean Section

Interventions: Drug: Intrathecal hydromorphone

First Posted Date: 2016-06-01

Last Posted Date: 2018-04-24

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 14

Registration Number: NCT02787928

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's

Not Applicable

Terminated

Conditions: Alzheimer's Disease

Interventions: Radiation: 10 GY in 5 daily fractions
Radiation: 20 GY in 10 daily fractions

First Posted Date: 2016-05-11

Last Posted Date: 2021-12-16

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 5

Registration Number: NCT02769000

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

High Dose Vitamin C in Cardiac Surgery Patients

Phase 1

Terminated

Conditions: Disorder of Vitamin C
Complications Due to Coronary Artery Bypass Graft
Atrial Fibrillation
Heart Valve Disease

Interventions: Drug: Placebo
Drug: Ascorbic Acid

First Posted Date: 2016-05-04

Last Posted Date: 2019-06-24

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 6

Registration Number: NCT02762331

Locations: 🇺🇸
Virginia Commonwealth University Health System, Richmond, Virginia, United States

Low Intensity Weight Loss for Young Adults

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Behavioral Weight Loss (BWL)
Behavioral: BWL + Autonomous Motivation
Behavioral: BWL + Extrinsic Motivation

First Posted Date: 2016-04-13

Last Posted Date: 2023-06-07

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 382

Registration Number: NCT02736981

Locations: 🇺🇸
Virginia Commonwealth University, School of Medicine, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy